Companies / Celldex Therapeutics, Inc. / Transactions
Back to Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

All insider transactions

1 transactions

Date ↓MoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Jan 2, 2026Other
Option exercise
Common StockMartin Samuel Bates
Executive
+4,817$10.38$50.0K32,942low
← PrevPage 1 of 1Next →